{"id":"W4408781448","doi":"10.1182/blood.2024027620","title":"Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"Celgene; National Cancer Institute; Kite Pharma; Yale University; Sanofi; Servier; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Daratumumab; Medicine; Internal medicine; Bortezomib; Minimal residual disease; Multiple myeloma; Thalidomide; Oncology; Surgery; Gastroenterology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001507164,0.0003181117,0.001040076,0.0001685941,0.0002344229,0.0004425149,0.0002212792,0.0002565132,0.001119403],"category_scores_gemma":[0.0005600202,0.00009222481,0.0006816065,0.0001893776,0.000298941,0.0002163055,0.0002205923,0.0006130598,0.000238448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005544545,"about_ca_system_score_gemma":0.0006623808,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005851249,"about_ca_topic_score_gemma":0.0013065,"domain_scores_codex":[0.9996595,0.000108636,0.00004919855,0.00008362446,0.00005217139,0.000046832],"domain_scores_gemma":[0.9995244,0.0001210512,0.00007862522,0.00008146869,0.00004587013,0.0001485669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4667437,0.01712891,0.04954883,0.0009920577,0.002609861,0.0005774758,0.0002152635,0.001632754,0.0928614,0.0004075313,0.001672819,0.3656094],"study_design_scores_gemma":[0.1229612,0.5379394,0.2574251,0.0001682245,0.004190338,0.002516116,0.000100811,0.002130183,0.0592271,0.0003943152,0.01289129,0.000056005],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953787,0.002726201,0.0003022126,0.0001514404,0.00005733733,0.000155289,0.0001675689,0.00001904273,0.001042135],"genre_scores_gemma":[0.9981475,0.000625733,0.0004108344,0.0000852384,0.0000352741,0.00005088381,0.0002281823,0.000004112042,0.0004123653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001507164,"threshold_uncertainty_score":0.00797075,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02871440592337437,"score_gpt":0.3321263116093556,"score_spread":0.3034119056859812,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}